Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-03

Clinical Trial Update: IMPACT of AspireSR® for VNS Therapy on Healthcare Resource Utilisation and Clinical Outcomes.

View source ↗

Summary

The update summarizes the IMPACT study evaluating AspireSR VNS Therapy for epilepsy and its effects on healthcare resource utilization and clinical outcomes; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AspireSR

Snippet

Sponsor: LivaNova | Conditions: Epilepsy | Status: TERMINATED